Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Rank

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Gastroenterology|June 1, 1989
Reversible cholestatic hepatitis caused by acetohexamideJ M Rank, R C Olson
Hepatology (Baltimore, Md.)|December 1, 1993
Evidence for neurological dysfunction in end-stage protoporphyric liver diseaseJ M Rank, R Carithers, J Bloomer
Annual Review of Medicine|January 1, 1990
Porphyria and porphyrin metabolismJ G Straka, J M Rank, J R Bloomer
Journal of Gastroenterology and Hepatology|September 1, 1990
Liver in disorders of porphyrin metabolismJ M Rank, J G Straka, J R Bloomer
Neurology|July 23, 1998
Neuropathy in erythropoietic protoporphyriasS A Muley, H A Midani, J M Rank, et al.
American Journal of Hematology|March 1, 1992
Hemolytic anemia in protoporphyria: possible precipitating role of liver failure and photic stressN S Key, J M Rank, D Freese, et al.
The Journal of Pediatrics|January 1, 1991
Hematin therapy for the neurologic crisis of tyrosinemiaJ M Rank, A Pascual-Leone, W Payne, et al.
British Journal of Haematology|August 1, 1990
Hematin therapy in late onset congenital erythropoietic porphyriaJ M Rank, J G Straka, M K Weimer, et al.
AJR. American Journal of Roentgenology|October 1, 1996
Effect of transjugular intrahepatic portosystemic shunt on quality of lifeG K Nazarian, H Ferral, H Bjarnason, et al.
Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 1, 1996
Follow-up after liver transplantation for protoporphyric liver diseaseJ R Bloomer, J M Rank, W D Payne, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Gastroenterology|June 1, 1989
Reversible cholestatic hepatitis caused by acetohexamideJ M Rank, R C Olson
Hepatology (Baltimore, Md.)|December 1, 1993
Evidence for neurological dysfunction in end-stage protoporphyric liver diseaseJ M Rank, R Carithers, J Bloomer
Annual Review of Medicine|January 1, 1990
Porphyria and porphyrin metabolismJ G Straka, J M Rank, J R Bloomer
Journal of Gastroenterology and Hepatology|September 1, 1990
Liver in disorders of porphyrin metabolismJ M Rank, J G Straka, J R Bloomer
Neurology|July 23, 1998
Neuropathy in erythropoietic protoporphyriasS A Muley, H A Midani, J M Rank, et al.
American Journal of Hematology|March 1, 1992
Hemolytic anemia in protoporphyria: possible precipitating role of liver failure and photic stressN S Key, J M Rank, D Freese, et al.
The Journal of Pediatrics|January 1, 1991
Hematin therapy for the neurologic crisis of tyrosinemiaJ M Rank, A Pascual-Leone, W Payne, et al.
British Journal of Haematology|August 1, 1990
Hematin therapy in late onset congenital erythropoietic porphyriaJ M Rank, J G Straka, M K Weimer, et al.
AJR. American Journal of Roentgenology|October 1, 1996
Effect of transjugular intrahepatic portosystemic shunt on quality of lifeG K Nazarian, H Ferral, H Bjarnason, et al.
Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 1, 1996
Follow-up after liver transplantation for protoporphyric liver diseaseJ R Bloomer, J M Rank, W D Payne, et al.
Pageof 2